The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EO2401 (E) peptide immunotherapy + nivolumab (N) +/- bevacizumab (B) in recurrent glioblastoma (GB): EOGBM1-18/ROSALIE.
 
Wolfgang Wick
Consulting or Advisory Role - MSD Oncology (Inst); Roche/Genentech (Inst)
Research Funding - Apogenix (Inst); Pfizer (Inst); Roche (Inst)
 
Ahmed Idbaih
Honoraria - Boehringer Ingelheim; Leo Pharma; Novartis; Novocure
Research Funding - CarThera (Inst); Nutrithéragene (Inst); Sanofi (Inst); SERVIER (Inst); Transgene (Inst)
Travel, Accommodations, Expenses - CarThera; Enterome; Novocure
 
Maria Vieito
Consulting or Advisory Role - BMS GmbH & Co. KG; Roche
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Novartis (Inst); Roche/Genentech (Inst); Taiho Oncology (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Roche
Other Relationship - BMS GmbH & Co. KG (Inst); Debiopharm Group (Inst); HUTCHMED (Inst); Incyte (Inst); Mundipharma (Inst); Novartis (Inst); PharmaMar (Inst); Roche (Inst); SERVIER (Inst); Taiho Oncology (Inst)
 
François Ghiringhelli
Honoraria - roche
Research Funding - AstraZeneca/MedImmune (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Roche/Genentech; Roche/Genentech
 
Agostina Stradella
Consulting or Advisory Role - Novartis; Seagan
Travel, Accommodations, Expenses - Novartis; Novartis
 
Ghazaleh Tabatabai
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis (Inst); Bayer Germany (Inst); Boehringer Ingelheim (Inst); CureVac (Inst)
 
Michael C. Burger
No Relationships to Disclose
 
Iris Mildenberger
No Relationships to Disclose
 
Ulrich Herrlinger
Consulting or Advisory Role - Bayer; Janssen
Speakers' Bureau - Medac
 
Patrick Y. Wen
Consulting or Advisory Role - AstraZeneca; Bayer; Black Diamond Therapeutics; Boehringer Ingelheim; Boston Pharmaceuticals; Celularity; Chimerix; Day One Biopharmaceuticals; ElevateBio; Genenta Science; GlaxoSmithKline; Insightec; Integral Health; Karyopharm Therapeutics; Merck; Mundipharma; Novartis; Novocure; Novocure; Nuvation Bio; Prelude Therapeutics; Prelude Therapeutics; Sagimet Biosciences; Sapience Therapeutics; Servier; Servier; Vascular Biogenics; VBI Vaccines
Research Funding - AstraZeneca (Inst); Bayer (Inst); Beigene (Inst); Celgene (Inst); Chimerix (Inst); Karyopharm Therapeutics (Inst); Kazia Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Oncoceutics (Inst); Puma Biotechnology (Inst); Servier (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)
 
Mehdi Touat
Consulting or Advisory Role - Agios; IntegraGen; Novocure; SERVIER; Taiho Pharmaceutical
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Merck Sharp & Dohme; SERVIER
 
Antje Wick
No Relationships to Disclose
 
Macarena González
Consulting or Advisory Role - Bayer; Ipsen
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Lilly; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
 
Alice Hervieu
Consulting or Advisory Role - Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Novartis
 
Marta Gil-Martin
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - GlaxoSmithKline; MSD Oncology
 
Mirjam Renovanz
No Relationships to Disclose
 
Ana Maia
Research Funding - Enterome; Enterome (Inst)
Travel, Accommodations, Expenses - Enterome
 
Christophe Bonny
Employment - Enterome
Leadership - Enterome
Stock and Other Ownership Interests - Enterome
Travel, Accommodations, Expenses - Enterome
 
Jan Fagerberg
Employment - Enterome
Leadership - Enterome
Stock and Other Ownership Interests - Enterome
Travel, Accommodations, Expenses - Enterome
 
David A. Reardon
Honoraria - Advantagene; Agenus; Anheart Therapeutics; Bayer; Bristol-Myers Squibb; Deciphera; DelMar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Imvax; Inovio Pharmaceuticals; Kintara Therapeutics; Kintara Therapeutics; KIYATEC; Medicenna; Merck; Merck KGaA; NEUVOGEN; Novocure; Oncorus; Regeneron; Sumitono Dainippon Pharma; Taiho Pharmaceutical; Taiho Pharmaceutical; Vivacitas Oncology; Y-mAbs Therapeutics
Consulting or Advisory Role - Advantagene; Agenus; Agios; Anheart Therapeutics; Bayer; Bristol-Myers Squibb; Delmar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Imvax; Kintara Therapeutics; Kiyatec; Medicenna; Merck; Merck KGaA; Novocure; Oncorus; Regeneron; Taiho Pharmaceutical; Vivacitas Oncology
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Enterome (Inst); Incyte (Inst); Omniox